Aevi Genomic Medicine Inc. (GNMX) Gained 5.65% or 0.07 To Price $1.31 On Wednesday


Aevi Genomic Medicine Inc. (GNMX) gained 5.65% or 0.07 to $1.31. It is near 413889 shares traded, which is 121.58% compare to the average total volume 340412. The market cap of GNMX is $77.73 million. The 52 week price range is from $0.98 to $6.18. Price of GNMX have changed 5.98% during last week. It have changed -0.80% over last month, -3.13% over last 3 months, -7.46% over last 6 months and -77.21% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for GNMX is 1.37. It is 4.58% above current price. The 200-day Moving Averages for GNMX is 1.43. It is 9.16% above current price. The 52-week High is 6.18. It is 371.76% from the current price. The 52-week Low is 0.98. It is -25.19% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of GNMX is 1.16 on 2017-12-15. Short % to float is 0.93%. There are some statistics of GNMX. It is has market cap $77.73 million. The share outstanding is 59.33 million. The average volume is 340412. The percent of top 15 Institution holding is 50.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of GNMX is -131.45%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of GNMX is -106.89%.


Tags:

Share this post